31 January

Bayer CEO's callous comments highlight failure of current biomedical innovation model

25 November

When politicians go to the movies

12 July

DG Trade State of Play reveals EU's ambitions for IP protection in FTAs

25 February

European drug regulator challenged over revolving door case involving former Director

1 February

Corporate funding linked to EU patient & consumer groups policy

20 December

EMA reviews transparency criteria

1 December

HAI research on financial disclosure featured in article: European politicians' call for greater transparency

22 October

HAI Europe Statement: EMA talks the ‘conflicts of interest’ talk, but will it walk the walk?

23 September

Dutch Minister of Health supports HAI E's financial transparency recommendations to EMA

2 September

Report exposes how Big Pharma has hijacked EU-India trade deal

30 August

In perspective: EMA comments on HAI Europe's survey of financial disclosure

25 August

Impact of HAI Europe survey results: Two weeks on

11 August

HAI Europe survey reveals new data on financial transparency of patient and consumer organisations

28 June

HAI Europe recommendations for improved conflict of interest declarations at EMA

23 June

ISDB & MiEF criticize EMA over conflict of interest procedures

14 June

Review of conflict of interest policies in three European medicines regulation agencies

11 May

EU Ombudsman: Transparency rules apply to all documents held by EMA

28 April

European Medicines Agency faces tough questions about patient groups' transparency

28 April

HAI hosts essay competition for students

26 April

Patient Groups need dose of transparency

22 April

Generic prescribing policies 1 – ABPI 0

21 April

Snooping CEO unveils conflicts of interest at the European Medicines Agency

29 March

Finnish study: Drug companies see added value of patient group sponsorship